openPR Logo
Press release

Hereditary Angioedema Therapeutics Market: Market Players Leveraging on Growth Opportunities | Takeda Pharmaceutical, CSL-Bering, Pharming Group NV, Sanofi-Aventis, Pfizer Inc., Ferring Pharmaceuticals Inc.

01-30-2023 07:57 AM CET | Health & Medicine

Press release from: Growth Plus Reports

Newark, New Castle, USA: According to the deep-dive market assessment study conducted by Growth Plus Reports, the global Hereditary Angioedema Therapeutics market was pegged at US$ 3.59 billion in 2021. The market is expected to witness a CAGR of 16 from 2022 to 2030.

Get a Sample PDF of the Report - https://www.growthplusreports.com/inquiry/request-sample/hereditary-angioedema-therapeutics-market/7996

The global Hereditary Angioedema Therapeutics Market has been analyzed for the forecast period 2022-2030 and historical period 2020. In order to help players to gain comprehensive understanding of the global Hereditary Angioedema Therapeutics Market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Furthermore, readers are offered with complete and thorough research on different regions and segments of the global Hereditary Angioedema Therapeutics Market . Almost all industry-specific, microeconomic, and macroeconomic factors influencing the global market growth have been analyzed in the report.

Key Players Mentioned in the Global Hereditary Angioedema Therapeutics Market Research Report: Takeda Pharmaceutical, CSL-Bering, Pharming Group NV, Sanofi-Aventis, Pfizer Inc., Ferring Pharmaceuticals Inc., Ionis Pharmaceuticals, Inc., BioCryst Pharmaceuticals, KalVista Pharmaceuticals, Ltd., Pharvaris Netherlands B.V., Intellia Therapeutics, Prothya Biosolutions, BioMarin Pharmaceutical

By Drug Class (C-1 Esterase Inhibitors, Kallikrein inhibitors, Bradykinin receptor inhibitor, Anabolic androgens, Antifibrinolytic drugs)

Key Reasons to Purchase:

To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the Hereditary Angioedema Therapeutics Market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the outlook and prospects for the market.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Hereditary Angioedema Therapeutics Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Hereditary Angioedema Therapeutics Market ?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

(6) What are the market opportunities and threats faced by vendors in the Global Hereditary Angioedema Therapeutics Market ?

Request for customization in Report: https://www.growthplusreports.com/inquiry/customization/hereditary-angioedema-therapeutics-market/7996

Detailed TOC of Global Hereditary Angioedema Therapeutics Market Growth (Status and Outlook) 2022-2030

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Hereditary Angioedema Therapeutics Market Executive Summary

2.1 World Market Overview

2.1.1 Global Market Size 2020-2030

2.1.2 Market Size CAGR by Region 2021 VS 2030

2.2 Hereditary Angioedema Therapeutics Market Segment by Type

2.2.1 Equipment

2.2.2 Materials

2.2.3 Services

Make an Inquiry before buying: https://www.growthplusreports.com/inquiry/before-buying/hereditary-angioedema-therapeutics-market/7996

https://www.globenewswire.com/news-release/2022/12/21/2577694/0/en/Electrophysiology-Devices-Market-Report-2022-to-2030-Siemens-Healthcare-AG-Abbott-Laboratories-General-Electric-Healthcare-Company-Medtronic-Plc-And-Boston-Scientific-Corp.html

https://www.globenewswire.com/news-release/2022/12/16/2575283/0/en/Knee-Replacement-Market-Size-2022-2030-Share-Industry-Trends-Growth-Challenges-and-Forecast-Growth-Plus-Reports.html

https://www.globenewswire.com/news-release/2022/12/20/2576815/0/en/Dental-CAD-CAM-Market-Size-2022-2030-Worth-US-4-41-Billion-To-grow-at-a-CAGR-of-8-60-Growth-Plus-Reports.html

https://finance.yahoo.com/news/compression-bandages-market-report-2022-134000144.html

https://www.globenewswire.com/news-release/2023/01/09/2585288/0/en/Neurological-Biomarkers-Market-Report-2022-to-2030-Abbott-Laboratories-Qiagen-ACOBIOM-DiaGenic-ASA-Olink-Biosciences.html

Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
Phone no: +44 808 238 7532
Web: https://www.growthplusreports.com/

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as ""Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hereditary Angioedema Therapeutics Market: Market Players Leveraging on Growth Opportunities | Takeda Pharmaceutical, CSL-Bering, Pharming Group NV, Sanofi-Aventis, Pfizer Inc., Ferring Pharmaceuticals Inc. here

News-ID: 2903531 • Views:

More Releases from Growth Plus Reports

Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation Therapies Redefining Treatment
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949 This latest report researches the industry structure,
Atypical Hemolytic Uremic Syndrome Treatment Market - Revolutionizing AHUS Care: Next-Generation Therapies Leading the Way
Atypical Hemolytic Uremic Syndrome Treatment Market - Revolutionizing AHUS Care: …
Newark, New Castle, USA: The "Atypical Hemolytic Uremic Syndrome Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Atypical Hemolytic Uremic Syndrome Treatment Market: https://www.growthplusreports.com/report/atypical-hemolytic-uremic-syndrome-treatment-market/8948 This latest report
Adenine Phosphoribosyltransferase Deficiency Therapeutics Market - Lighting the Path to Relief: APRT Therapeutics Paving the Way
Adenine Phosphoribosyltransferase Deficiency Therapeutics Market - Lighting the …
Newark, New Castle, USA: The "Adenine Phosphoribosyltransferase Deficiency Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Adenine Phosphoribosyltransferase Deficiency Therapeutics Market: https://www.growthplusreports.com/report/adenine-phosphoribosyltransferase-deficiency-therapeutics-market/8946 This latest report researches the
Mycobacterium Bovis Treatment Market - Revolutionizing Mycobacterium Bovis Treatment: Breakthroughs in Combating the Infection
Mycobacterium Bovis Treatment Market - Revolutionizing Mycobacterium Bovis Treat …
Newark, New Castle, USA: The "Mycobacterium Bovis Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Mycobacterium Bovis Treatment Market: https://www.growthplusreports.com/report/mycobacterium-bovis-treatment-market/8945 This latest report researches the industry structure,

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant